Supernus Pharmaceuticals Inc (SUPN)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | 379,252 | 361,751 | 345,170 |
| Total assets | US$ in thousands | 1 | 1,702,510 | 1,689,150 | 1,504,100 | 1,160,280 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.22 | 0.24 | 0.30 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1K
= 0.00
The debt-to-assets ratio of Supernus Pharmaceuticals Inc has exhibited a declining trend over the past five years, reflecting the company's ability to finance its operations with less reliance on debt. As of December 31, 2023, the company reported a debt-to-assets ratio of 0.00, indicating that it had no debt relative to its total assets, which could suggest a strong financial position with low financial risk.
Comparing this to the previous years, the company had a higher debt-to-assets ratio in 2022, 2021, 2020, and 2019, which indicates a positive trend of reducing debt levels relative to its assets. This reduction in the debt-to-assets ratio over the years may indicate that Supernus Pharmaceuticals Inc has been paying down its debt obligations and/or growing its asset base without incurring additional debt.
A debt-to-assets ratio of 0.00 indicates that the company's assets are entirely financed by equity, which can be viewed positively by investors and creditors as it signifies lower financial leverage and lower risk of insolvency. Overall, the declining trend in the debt-to-assets ratio suggests that Supernus Pharmaceuticals Inc has been effectively managing its debt levels and maintaining a strong financial position.
Peer comparison
Dec 31, 2023